Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 10, 2025 | FINT | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Dec 23, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Dec 23, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Mar 25, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Mar 6, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 6, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Dec 22, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Dec 22, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Dec 22, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 3, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jun 9, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jun 9, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Apr 22, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Apr 21, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 20, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 4, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Sep 30, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 29, 2022 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for prevention or treatment of cardiovascular diseases, hypertension, vasospasms associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, autoimmune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, insomnia, anxiety disorders, drug addiction, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases and cancer
Additional Information
Pseudo Mark
IDORSIA
Classification
International Classes
005